Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 11 July 2018

Indication(s)

Aerius 5 mg film-coated tablets
Aerius 5 mg orodispersible tablets:

Aerius is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:
- allergic rhinitis
- urticaria


Aerius 2.5 mg orodispersible tablets:
Aerius is indicated in adults, adolescents aged 12 years and older and children aged 6 – 11 years old for the relief of symptoms associated with:
- allergic rhinitis
- urticaria


Aerius 0.5 mg/ml oral solution:
Aerius is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with:
- allergic rhinitis
- urticaria

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/000313
Orphan designation No
Date First Approved 15-01-2001
Type Medicinal product subject to medical prescription
Marketing authorisation holder Merck Sharp & Dohme B.V.